Author:
Kappler M,Rot S,Taubert H,Greither T,Bartel F,Dellas K,Hänsgen G,Trott K-R,Bache M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference49 articles.
1. Altieri DC . Targeted therapy by disabling crossroad signaling networks: the survivin paradigm. Mol Cancer Ther 2006; 5: 478–482.
2. Altieri DC . Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003; 3: 46–54.
3. Kappler M, Kohler T, Kampf C, Diestelkotter P, Wurl P, Schmitz M et al. Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer 2001; 95: 360–363.
4. Kappler M, Kotzsch M, Bartel F, Fussel S, Lautenschlager C, Schmidt U et al. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin Cancer Res 2003; 9: 1098–1104.
5. Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM et al. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2000; 2: 235–241.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献